LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 156 filers reported holding LEGEND BIOTECH CORP in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,649,952 | +1.5% | 352,091 | +4.3% | 0.14% | -0.7% |
Q2 2023 | $23,296,590 | +73.2% | 337,485 | +21.0% | 0.14% | +75.6% |
Q1 2023 | $13,450,583 | -40.6% | 278,942 | -38.5% | 0.08% | -33.9% |
Q4 2022 | $22,644,860 | -10.1% | 453,623 | -26.5% | 0.12% | -3.1% |
Q3 2022 | $25,188,000 | -19.9% | 617,350 | +8.0% | 0.13% | -3.8% |
Q2 2022 | $31,437,000 | +59.3% | 571,587 | +5.2% | 0.13% | +66.2% |
Q1 2022 | $19,740,000 | +264.6% | 543,206 | +367.6% | 0.08% | +158.1% |
Q4 2021 | $5,414,000 | – | 116,159 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 814,586 | $54,715,742 | 20.16% |
HHLR ADVISORS, LTD. | 6,436,533 | $432,341,922 | 9.65% |
Paradigm Biocapital Advisors LP | 2,025,480 | $136,051,492 | 9.23% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,828 | $75,487,527 | 9.13% |
RA Capital Management | 6,264,707 | $420,800,369 | 8.28% |
Iron Triangle Partners LP | 452,629 | $30,403,090 | 4.44% |
Nicholas Investment Partners, LP | 593,010 | $39,832,482 | 2.98% |
Old Well Partners, LLC | 45,200 | $3,036,084 | 2.63% |
Avidity Partners Management LP | 967,000 | $64,953,390 | 2.62% |
E Fund Management (Hong Kong) Co., Ltd. | 52,759 | $3,544 | 2.23% |